1. Home
  2. TYL vs MEDP Comparison

TYL vs MEDP Comparison

Compare TYL & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyler Technologies Inc.

TYL

Tyler Technologies Inc.

HOLD

Current Price

$339.51

Market Cap

13.5B

Sector

Technology

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$419.81

Market Cap

11.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYL
MEDP
Founded
1966
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5B
11.7B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
TYL
MEDP
Price
$339.51
$419.81
Analyst Decision
Buy
Hold
Analyst Count
12
12
Target Price
$476.50
$473.17
AVG Volume (30 Days)
428.8K
451.2K
Earning Date
04-29-2026
04-22-2026
Dividend Yield
N/A
N/A
EPS Growth
19.01
20.98
EPS
1.88
4.28
Revenue
$493,101,000.00
N/A
Revenue This Year
$9.55
$13.19
Revenue Next Year
$9.75
$7.75
P/E Ratio
$49.48
$96.40
Revenue Growth
18.35
N/A
52 Week Low
$283.72
$284.10
52 Week High
$621.34
$628.92

Technical Indicators

Market Signals
Indicator
TYL
MEDP
Relative Strength Index (RSI) 47.86 37.09
Support Level $322.57 $382.68
Resistance Level $355.41 $485.13
Average True Range (ATR) 12.29 17.73
MACD 1.57 -11.32
Stochastic Oscillator 37.93 29.20

Price Performance

Historical Comparison
TYL
MEDP

About TYL Tyler Technologies Inc.

Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: